Engaging with the CDA-AMC Vision for Canada in 2026

Understand the priorities of the CDA-AMC’s expanded role in 2025 and its direction into 2026. Assess the impact of this development on your organization by learning about the existing and emerging core functions of Canada’s Drug Agency. Walk away with an action plan on:

• Leading national efforts on a pan-Canadian appropriate use and prescribing program.
• Enhancing patient experience through data and analytics.
• Improving system coordination across Canada.

Advance your market access strategy with direct guidance from the CDA-AMC to align with national priorities and support equitable access for patients across Canada.